| J2777 | Injection, faricimab‑svoa, 0.1 mg | 44,220 | $30 | $1.3M |
| J0178 | Injection, aflibercept, 1 mg | 1,060 | $680 | $725K |
| J2778 | Injection, ranibizumab, 0.1 mg | 2,270 | $180 | $406.7K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,490 | $120 | $171.8K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,580 | $30 | $87.6K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 850 | $100 | $85.2K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 310 | $220 | $67.5K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 870 | $80 | $66.8K |
| J7999 | Compounded drug, not otherwise classified | 120 | $70 | $8.6K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 90 | $90 | $8.5K |